Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Guardado en:
Detalles Bibliográficos
Autores principales: Maki Komiyama, Koji Hasegawa
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2020
Materias:
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/c0c333e79ecd4257a1136f413dd20082
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0c333e79ecd4257a1136f413dd20082
record_format dspace
spelling oai:doaj.org-article:c0c333e79ecd4257a1136f413dd200822021-12-04T16:03:20ZResponse to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 201910.15420/ecr.2020.251758-37641758-3756https://doaj.org/article/c0c333e79ecd4257a1136f413dd200822020-07-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2020.25https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Maki KomiyamaKoji HasegawaRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 15, Iss , Pp - (2020)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Maki Komiyama
Koji Hasegawa
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
format article
author Maki Komiyama
Koji Hasegawa
author_facet Maki Komiyama
Koji Hasegawa
author_sort Maki Komiyama
title Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
title_short Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
title_full Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
title_fullStr Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
title_full_unstemmed Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
title_sort response to the comment ‘smoking and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker cessation to limit coronavirus disease 2019
publisher Radcliffe Medical Media
publishDate 2020
url https://doaj.org/article/c0c333e79ecd4257a1136f413dd20082
work_keys_str_mv AT makikomiyama responsetothecommentsmokingandangiotensinconvertingenzymeinhibitorangiotensinreceptorblockercessationtolimitcoronavirusdisease2019
AT kojihasegawa responsetothecommentsmokingandangiotensinconvertingenzymeinhibitorangiotensinreceptorblockercessationtolimitcoronavirusdisease2019
_version_ 1718372757759066112

Ejemplares similares